<code id='96D47B76D1'></code><style id='96D47B76D1'></style>
    • <acronym id='96D47B76D1'></acronym>
      <center id='96D47B76D1'><center id='96D47B76D1'><tfoot id='96D47B76D1'></tfoot></center><abbr id='96D47B76D1'><dir id='96D47B76D1'><tfoot id='96D47B76D1'></tfoot><noframes id='96D47B76D1'>

    • <optgroup id='96D47B76D1'><strike id='96D47B76D1'><sup id='96D47B76D1'></sup></strike><code id='96D47B76D1'></code></optgroup>
        1. <b id='96D47B76D1'><label id='96D47B76D1'><select id='96D47B76D1'><dt id='96D47B76D1'><span id='96D47B76D1'></span></dt></select></label></b><u id='96D47B76D1'></u>
          <i id='96D47B76D1'><strike id='96D47B76D1'><tt id='96D47B76D1'><pre id='96D47B76D1'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:52
          Ruby Wallau for STAT

          NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

          But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

          advertisement

          That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more
          STAT Wunderkinds: Ruey Hu's digital tools for parsing research
          STAT Wunderkinds: Ruey Hu's digital tools for parsing research

          HugraduatingfromJohnsHopkinsandbeinginductedintotheDeltaOmegaPublicHealthHonorSocietyin2017.Courtesy

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Readout Newsletter: What happened with Sarepta's Duchenne data

          AndrewHarnik/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnews